RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

Kennedy Jr. A number lambasted Kennedy and the FDA on social media recently when the regulatory agency approved Moderna’s second-generation Covid-19 vaccine, known as mNexspike. Unlike earlier ...

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s been significantly impacted by the recent changes in FDA and HHS leadership.

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...

Helen Chu, MD, urged doctors to find "science-based recommendations" from the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of ...